Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H22N4O2S |
| Molecular Weight | 358.458 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC[C@@H](CC(C)C)NC1=N\C(=C/C2=CC=C3N=CSC3=C2)C(=O)N1
InChI
InChIKey=CHQYAWLKOUOTQO-QVYJARAXSA-N
InChI=1S/C18H22N4O2S/c1-11(2)6-13(9-24-3)20-18-21-15(17(23)22-18)7-12-4-5-14-16(8-12)25-10-19-14/h4-5,7-8,10-11,13H,6,9H2,1-3H3,(H2,20,21,22,23)/b15-7-/t13-/m1/s1
| Molecular Formula | C18H22N4O2S |
| Molecular Weight | 358.458 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 19:33:43 GMT 2025
by
admin
on
Wed Apr 02 19:33:43 GMT 2025
|
| Record UNII |
F5A38P48PV
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
F5A38P48PV
Created by
admin on Wed Apr 02 19:33:43 GMT 2025 , Edited by admin on Wed Apr 02 19:33:43 GMT 2025
|
PRIMARY | |||
|
300000051401
Created by
admin on Wed Apr 02 19:33:43 GMT 2025 , Edited by admin on Wed Apr 02 19:33:43 GMT 2025
|
PRIMARY | |||
|
162346700
Created by
admin on Wed Apr 02 19:33:43 GMT 2025 , Edited by admin on Wed Apr 02 19:33:43 GMT 2025
|
PRIMARY | |||
|
2732859-77-5
Created by
admin on Wed Apr 02 19:33:43 GMT 2025 , Edited by admin on Wed Apr 02 19:33:43 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
IC50
|
||
|
OFF-TARGET->INHIBITOR |
IC50
|
||
|
|
OFF-TARGET->INHIBITOR |
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Down Syndrome and Alzheimer’s Disease Drug Candidate
|